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Introduction
Normal epithelium is separated from the underlying stroma by 
a specialized layer of ECM, the basement membrane (BM). 
During localized invasion and metastasis, invasive carcinoma 
cells break through this barrier, commonly by proteolytic re-
modeling of the BM, and penetrate into the interstitial matrix 
of the stroma (Hoshino et al., 2013). The acquired ability of 
carcinoma cells to proteolytically remodel the ECM is often 
supported by their capacity to form invadopodia, which are 
dynamic, actin cytoskeleton–supported membrane protrusions 
that function as sites for intracellular trafficking and secretion 
of matrix metalloproteases (MMPs; Murphy and Courtneidge, 
2011; Hoshino et al., 2013). Upon BM perforation, invadopo-
dia are converted into larger pseudopodia structures, allowing 
carcinoma cells to transmigrate through the BM and invade into 
the stroma, thus initiating the process of metastasis to distant 
organs (Schoumacher et al., 2010).
Invadopodia biogenesis is triggered through the onco-
genic activity or activation of multiple cell surface receptors, 
whose signals converge on downstream regulatory signaling 
molecules involved in cytoskeletal organization. Of these, 
class I phosphoinositide-3-kinase (PI3K), an enzyme that 
phosphorylates the D3 position of the inositol ring of phos-
phatidylinositol(4,5)-bisphosphate (PtdIns(4,5)P2) to produce 
PtdIns(3,4,5)-triphosphate (PtdIns(3,4,5)P3), has recently 
emerged as a critical regulator of invadopodia (Hoshino et 
al., 2012). Inhibition of PI3K activity or sequestration of D3 
phosphoinositides attenuates invadopodia formation, whereas 
a constitutively active p110 subunit of PI3K enhances invado-
podia-mediated ECM degradation (Yamaguchi et al., 2011). 
Mechanistically, enrichment of PtdIns(3,4,5)P3 at sites of inv-
adopodia initiation coincides with recruitment of regulators of 
the Arp2/3 actin nucleation complex, cortactin and N-WASP. 
Together these suffice for initiation of invadopodia assem-
bly through enhanced nucleation of branched actin filaments 
(Sharma et al., 2013). In contrast, invadopodia maturation into 
proteolytically active structures (comprising membrane pro-
trusions), coupled with targeted trafficking of MMPs, requires 
local accumulation of phosphoinositide, PtdIns(3,4)P2 (Sharma 
et al., 2013). Dephosphorylation of PtdIns(3,4,5)P3 at the D5 
position of the inositol ring by 5′-inositol phosphatases, in-
cluding SHIP2, yields PtdIns(3,4)P2 (Ooms et al., 2009). Lo-
calized accumulation of PtdIns(3,4)P2 at nascent invadopodia 
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leads to recruitment of several effector proteins, including the 
Tks4/Tks5 family of adaptors that are believed to sustain inv-
adopodia maturation through regulation of further nucleation 
of actin filaments and targeted delivery of MT1-MMP (Sharma 
et al., 2013). Although sustained Arp2/3-mediated branched 
actin filament nucleation at nascent membrane protrusions has 
emerged as a crucial regulatory step for invadopodia formation, 
little is known about how subsequent actin filament elongation 
contributes to the maturation process. In this respect, Mena 
and VASP, members of the enabled (Ena)/vasodilator-stimu-
lated phosphoprotein (VASP) family involved in actin filament 
elongation, localize to invadopodia, and overexpression of an 
invasion-associated isoform of Mena (MenaINV) can prolong 
invadopodia lifetime (Philippar et al., 2008; Schoumacher et 
al., 2010). However, mechanisms for recruitment or the poten-
tial functional redundancy of Mena and VASP for invadopodia 
biogenesis remain unknown.
Here, we investigate the role of the 5′-inositol phospha-
tase, SHIP2, in maturation of invadopodia. Our analyses reveal 
that in addition to its lipid phosphatase activity, SHIP2 functions 
as a scaffold critical for recruitment of Mena to invadopodia. 
Uncoupling SHIP2–Mena interactions in cancer cells leads to 
decreased stability of invadopodia, resulting in attenuated ECM 
degradation in vitro and metastatic capacity in vivo. Together, 
these findings provide new insight into molecular mechanisms 
underlying invadopodia maturation into proteolytically active 
structures and highlight the importance of an unexpected scaf-
fold function of SHIP2 as a key modulator of cell invasion and 
a potential therapeutic target for metastatic disease.
Results
SHIP2 regulation of invadopodia requires 
an intact proline-rich sequence and its 
phosphatase activity
Invadopodia-related functions of SHIP2 were supported by 
knockdown experiments and were attributed to its enzymatic 
activity using a small molecule inhibitor (AS1949490; Sharma 
et al., 2013). However, no detailed structure–function analyses 
have been performed, and additional roles for SHIP2 have not 
been explored. To identify protein interaction modules and part-
ners of SHIP2 that contribute to invadopodia maturation, we 
evaluated a panel of SHIP2 mutants for their ability to form in-
vadopodia competent to degrade the ECM. The panel of SHIP2 
mutants lack specific domains (SH2 and proline-rich sequence 
[PRS]) and contain amino acid substitutions of specific tyrosine 
residues (Y886 and Y1135) implicated in cell invasion when ty-
rosine phosphorylated in response to growth factor stimulation 
(Johnson et al., 2013), as well as a catalytically inactive SHIP2 
mutant (D608A; Ooms et al., 2009; Fig. 1 A).
Stable depletion of SHIP2 in invasive MDA-MB-231 
breast cancer cells results in 35% fewer cells with proteolyt-
ically active invadopodia (Fig. S1, A and B) and a 54% de-
crease in overall matrix degradation capacity (Fig. S1, A and 
C). However, SHIP2 depletion does not affect the ability of 
MDA-MB-231 cells to form ventrally located, cortactin-pos-
itive, F-actin–rich punctate structures (Fig. S1, D and E). 
Consistent with the decrease in invadopodia-mediated ECM 
degradation, SHIP2 depletion results in a 36% decrease in cell 
invasion through 3D matrix (Fig. S1, F and G), although no 
noticeable differences are observed in 2D cell migration param-
eters, including speed of migration or persistence (Video 1 and 
Fig. S2). Collectively, these data argue that the contribution of 
SHIP2 to cell invasion is predominantly mediated through its 
invadopodia-mediated matrix remodeling capacity.
Populations of SHIP2-depleted cells stably expressing 
each SHIP2 mutant (Fig. 1 B) were established and assayed for 
their ability to form proteolytically active invadopodia and for 
overall ECM degradation capacity. Reexpression of wild-type 
(WT) SHIP2 rescued both invadopodia formation (114% of 
pLKO.1) and ECM degradation (139% of pLKO.1) to levels 
similar to or greater than those of control cells expressing en-
dogenous SHIP2 (Fig. 1, C–E). The ability of SHIP2-depleted 
cells to form invadopodia and degrade the ECM was also res-
cued by expression of SHIP2-Y886F and SHIP2-Y1135F mu-
tants, indicating that phosphorylation of these tyrosine residues 
is not required for SHIP2-dependent invadopodia-mediated 
ECM degradation (Fig. 1, C–E).
In contrast, several SHIP2 mutants displayed decreased 
ability to rescue invadopodia formation and ECM degra-
dation after SHIP2 knockdown. The catalytically inactive 
SHIP2 mutant (D608A; Ooms et al., 2009) failed to rescue 
invadopodia formation (65% of pLKO.1) and ECM degrada-
tion (59% of pLKO.1) to levels of WT SHIP2 (Fig. 1, C–E). 
This is consistent with the ability of SHIP2 to catalyze con-
version of PtdIns(3,4,5)P3 to PtdIns(3,4)P2, which is required 
for recruitment of the Tks5 scaffold protein and stabilization of 
the branched actin nucleation complex, consisting of Arp2/3, 
N-WASP, and cortactin (Sharma et al., 2013). Similarly, a mod-
erate but consistent decrease in ability to rescue invadopodia 
formation (87.5% of pLKO.1) and ECM degradation (86% of 
pLKO.1) was observed for the SHIP2ΔSH2 mutant (Fig.  1, 
C–E). Several SHIP2 SH2 domain–interacting proteins, in-
cluding p130Cas, localize to invadopodia (Prasad et al., 2001; 
Alexander et al., 2008), supporting that optimal recruitment of 
SHIP2 to invadopodia may be mediated by its SH2 domain.
Most strikingly, a SHIP2 mutant that retains phosphatase 
activity and an intact SH2 domain, but lacks a C-terminal PRS 
(SHIP2ΔPPP DFP PPP, referred to as SHIP2ΔFP4), showed 
decreased ability to rescue invadopodia formation (65% of 
pLKO.1) and overall ECM degradation (49% of pLKO.1) 
to levels similar to the phosphatase-inactive mutant (SHIP2-
D608A; Fig. 1, C–E). The SHIP2ΔFP4 mutant localized to in-
vadopodia (Fig. S3, A and B), indicating no requirement for 
the PRS (PPP DFP PPP) for SHIP2 recruitment, instead sup-
porting a role for the PRS in invadopodia maturation and ECM 
degradation. Consistent with their inability to rescue invado-
podia-mediated matrix remodeling, the SHIP2ΔSH2, SHIP2-
D608A, and SHIP2ΔFP4 mutants showed reduced ability to 
rescue cell invasion (50%, 62%, and 63% of WT-SHIP2, re-
spectively; Fig. 1, F and G).
SHIP2 recruitment to invadopodia requires 
an intact SH2 domain
Invadopodia are composed of multiple cytoskeletal, trafficking, 
and scaffold proteins. Among these, Tks5 has emerged as a scaf-
fold protein required for invadopodia stability and functional 
integrity (Murphy and Courtneidge, 2011). To assess whether 
Tks5 recruitment to invadopodia is altered in cells expressing 
SHIP2 mutants with diminished capacity to rescue matrix deg-
radation (SHIP2ΔSH2, SHIP2-D608A, and SHIP2ΔFP4), we 
performed quantification of Tks5 content in ventrally located 
membrane protrusions that stained positive for the invadopodia 
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Figure 1. Proteolytically active invadopodia formation requires both the phosphatase activity and the scaffolding functions of SHIP2. (A) Schematic 
diagram of SHIP2 depicts its SH2 domain, inositol phosphatase domain, SAM domain, proline-rich region, and several phosphorylated tyrosine residues 
(Y886, Y996, and Y1135). (B) MDA-MB-231 cells stably expressing SHIP2 shRNA (shSHIP2-C) were transduced with retroviral vectors containing a 
panel of shRNA-resistant SHIP2 mutants. Upon selection for stable expression of SHIP2 mutants, cell lysates were separated by SDS-PAGE and probed 
as indicated to assess the protein level of SHIP2 mutants. (C) MDA-MB-231 cells stably expressing SHIP2 shRNA were transduced with retroviral vectors 
containing a panel of shRNA-resistant SHIP2 mutants. Upon selection for stable expression of SHIP2 mutants, cells were cultured on fluorescently labeled 
gelatin, and abilities of different SHIP2 mutants to rescue SHIP2 knockdown-induced invadopodia formation (percentage of cells positive for F-actin punc-
tate overlaying matrix degradation area) and ECM degradation (mean matrix degradation area per fields of view) phenotypes were compared. (D) ECM 
degradation by cells expressing different SHIP2 mutants was quantified and expressed as the fold change of control (pLKO.1). (E) Percentage of cells that 
form proteolytically active invadopodia in cells expressing different SHIP2 mutants was quantified in comparison to control (pLKO.1). (F) SHIP2-depleted 
MDA-MB-231 cells rescued with shRNA-resistant wild-type SHIP2 or SHIP2 mutants (ΔSH2, D608A, and ΔFP4) were subjected to an inverted invasion 
assay. Representative confocal z-stack from each condition depicts relative cell invasion. (G) For quantification of cell invasion, five confocal z-stacks per 
condition per experiment were acquired. Fluorescence intensity of the planes within each z-stack was measured using Cell Profiler software. Cells invading 
to and past 30 µm inside the matrix were quantified as a percentage of total cell population. Experiments were repeated four times. All quantified data 
indicate the mean values ± SE from at least four independent experiments. *, P < 0.05; **, P < 0.01. Bars, 10 µm.
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marker proteins cortactin and F-actin. Whereas the majority of 
invadopodia (91%) from MDA-MB231-shSHIP2 cells rescued 
with WT-SHIP2 scored positive for Tks5, only 54% and 57% of 
invadopodia from cells rescued with SHIP2ΔSH2 and SHIP2-
D608A, respectively, were positive for Tks5 (Fig. 2, A and B). 
Recruitment of Tks5 to nascent invadopodia is thought to be 
mediated via its N-terminally located PtdIns(3,4)P2-binding 
Phox-homology (PX) domain. Given that SHIP2 catalytic activ-
ity generates PtdIns(3,4)P2 from PtdIns(3,4,5)P3, it is feasible 
that reduced recruitment of Tks5 to invadopodia sites in cells 
expressing the catalytically inactive mutant of SHIP2 (SHIP2-
D608A) is caused by decreased production of PtdIns(3,4)P2.
Our data indicate that the SHIP2ΔSH2 mutant that retains 
catalytic activity has reduced ability to promote recruitment of 
Tks5 to nascent invadopodia. Because SHIP2 localizes to the 
cytosol and translocates to the plasma membrane in response 
to extracellular stimuli through interactions involving its SH2 
domain (Pesesse et al., 2001; Prasad et al., 2001; Ishihara et 
al., 2002; Smith et al., 2010), we rationalized that reduced re-
cruitment of Tks5 to nascent invadopodia may be caused by 
impaired localization of SHIP2ΔSH2. In agreement with this, a 
SHIP2 mutant, SHIP2ΔFP4-R47G, that renders the SH2 domain 
unable to bind phosphotyrosine (R47G; Prasad et al., 2009) and 
is unable to engage with Mena tetramers bound to endogenous 
Figure 2. SHIP2 is recruited to invadopodia via its SH2 domain, possibly through an interaction with cortactin. (A) SHIP2-depleted MDA-MB-231 cells 
rescued with shRNA-resistant wild-type SHIP2 or SHIP2 mutants (ΔSH2, D608A, and ΔFP4) were immunostained for invadopodia markers cortactin and 
Tks5, and confocal sections were acquired at the ventral surface. (B) As in A, MDA-MB-231-shSHIP2 cells rescued with WT-SHIP2, SHIP2 ΔSH2, SHIP2-
D608A, or SHIP2ΔFP4 were immunostained for F-actin (phalloidin), cortactin, and Tks5. Percentage of F-actin– (phalloidin) and cortactin-positive punctae 
at the ventral surface of cells that were also positive for Tks5 was quantified based on three independent experiments. (C) Cell lysates were isolated from 
MDA-MB-231 cells transiently transfected with GFP-SHIP2 or GFP-SHIP2ΔFP4-R47G. WT-SHIP2 or SHIP2ΔFP4-R47G was immunoprecipitated using GFP 
antibody, and immunoprecipitates were separated by SDS-PAGE and probed as indicated. (D) MDA-MB-231 cells were transiently transfected with ta-
gRFP-LifeAct and GFP-SHIP2 and subjected to time-lapse video microscopy analysis. Single frame depicts SHIP2 localization with respect to actin punctae. 
(E) MDA-MB-231 cells were transiently transfected with tagRFP-LifeAct and GFP-SHIP2ΔFP4-R47G and subjected to time-lapse video microscopy analysis. 
Single frame illustrates that GFP-SHIP2ΔFP4-R47G failed to localize to actin punctae. All quantified data indicate the mean values ± SE from at least three 
independent experiments. **, P < 0.01. Bars: 10 µm; (inset) 2 µm.
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wild-type SHIP2 (SHIP2ΔFP4) fails to localize to ventral F- 
actin–positive protrusions (Video 2 and Fig. 2 D). However, a 
SHIP2ΔFP4 mutant with an intact SH2 domain still localizes to 
ventral F-actin–positive protrusions, demonstrating requirement 
for an intact SH2 domain for SHIP2 recruitment (Fig. S3, A 
and B). Collectively, these data establish that a functional SH2 
domain is critical for localization of SHIP2 to invadopodia sites.
Cortactin precedes SHIP2 recruitment to nascent mem-
brane protrusions at sites of invadopodia (Sharma et al., 2013), 
and cortactin is tyrosine phosphorylated in response to multiple 
receptor and nonreceptor tyrosine kinases (Ammer and Weed, 
2008; Weaver, 2008). To test whether cortactin recruits SHIP2 
to nascent invadopodia, we performed coimmunoprecipitation 
of endogenous cortactin with exogenously expressed GFP-
SHIP2 or GFP-SHIP2ΔSH2 in MDA231 cells. An interaction 
was observed between endogenous cortactin with exogenous 
SHIP2, which is dependent on the integrity of the SHIP2 SH2 
domain (Fig. 2 C). Collectively, these data support the ability of 
tyrosine-phosphorylated cortactin to recruit SHIP2 to nascent 
invadopodia via its SH2 domain.
SHIP2 interacts with Mena and VASP
To identify interaction partners for the SHIP2 PRS required for 
invadopodia maturation, we first tested known binding part-
ners of SHIP2 PRS. The SH3 domains of the endocytic adaptor 
protein, intersectin, associates with the PPP DFP PPP motif of 
SHIP2 (Nakatsu et al., 2010). However, depletion of intersectin 
failed to abrogate invadopodia formation or ECM degradation 
(Fig. S4), suggesting that SHIP2-dependent invadopodia for-
mation and ECM degradation are mediated by other binding 
partners of its PRS motif. Intriguingly, the PPP DFP PPP motif 
of SHIP2 harbors a putative FPP PP (FP4) consensus sequence 
for the EVH1 domain of the Ena/VASP family of proteins 
(Fig. 3 A; Carl et al., 1999; Ball et al., 2000; Bear and Gertler, 
2009). Ena/VASP proteins elongate actin filaments and pos-
sess actin barbed-end anticapping properties (Bear et al., 2002; 
Barzik et al., 2005; Hansen and Mullins, 2010; Breitsprecher 
et al., 2011), hence playing a significant role in cellular pro-
cesses dependent on actin filament dynamics, particularly at the 
leading edge of lamellipodia and tips of filopodia (Krause et 
al., 2002, 2003; Murphy and Courtneidge, 2011; Carmona et 
al., 2016). In addition, two members of the Ena/VASP protein 
family, Mena and VASP, localize at invadopodia sites (Philippar 
et al., 2008; Schoumacher et al., 2010). To determine whether 
Mena or VASP interacts with SHIP2 in MDA-MB-231 cells, we 
performed reciprocal immunoprecipitations of SHIP2 and Ena/
VASP proteins from cell lysates. We found that both Mena and 
VASP coimmunoprecipitate with endogenous SHIP2 (Fig.  3, 
B–D) as well as exogenously expressed WT-SHIP2 (Fig. 3, E 
and F), but not with an exogenously expressed SHIP2ΔFP4 
mutant (Fig.  3, E and F). Under these conditions, interaction 
between SHIP2 and a third member of the Ena/VASP family 
of proteins, EVL, was not detected, likely because of low en-
dogenous levels of EVL in MDA-MB-231 cells compared with 
Mena and VASP (not depicted).
To establish whether the EVH1 domains of Mena 
and VASP interact with the FP4 motif in SHIP2, we created 
MenaΔEVH1 and VASPΔEVH1 mutants and analyzed their 
ability to coimmunoprecipitate with SHIP2. Surprisingly, when 
overexpressed, both MenaΔEVH1 and VASPΔEVH1 coim-
munoprecipitated with SHIP2 (Fig. 3, G and H). Because both 
Mena and VASP are able to tetramerize through their C-terminal 
coiled-coil domains (Loureiro et al., 2002; Bear and Gertler, 
2009), we hypothesized that MenaΔEVH1 and VASPΔEVH1 
could form mixed tetramers with endogenous Mena and VASP, 
respectively, allowing indirect interaction with WT-SHIP2. In 
agreement with this hypothesis, we established that simultane-
ous deletion of the coiled-coil and EVH1 domains from Mena 
and VASP abrogates binding with SHIP2, whereas loss of either 
domain alone is insufficient to disrupt the interactions (Fig. 3, 
G and H). To establish whether the EVH1 domains alone are 
sufficient for the interactions between SHIP2 and Mena/VASP, 
we used GST-fused EVH1 domains of VASP and Mena as baits 
to capture binding proteins from the cell lysates. In these ex-
periments, both SHIP2 and vinculin (another known binding 
partner of Mena/VASP proteins) were efficiently captured, fur-
ther demonstrating that EVH1 domains of Mena and VASP are 
sufficient for interaction with SHIP2 (Fig. 3 I). Collectively, our 
results reveal that SHIP2 interacts with Mena and VASP via an 
EVH1-binding site in SHIP2. These findings indicate that in ad-
dition to its role in generating PI(3,4)P2, SHIP2 may promote 
invadopodia maturation through its scaffolding functions, that 
is, through physical recruitment of Mena and/or VASP.
SHIP2 recruits Mena, but not VASP, to 
invadopodia to confer functionality
When plated on fluorescent gelatin matrix, MDA-MB-231 cells 
form invadopodia that actively degrade ECM. The F-actin–rich 
cores of these structures can be identified during time-lapse 
live cell imaging using LifeAct fluorescent probe (Fig. S3 C 
and Video 3). Using this time-lapse microscopy approach, we 
observed that localization of VASP and Mena differs within 
invadopodia. Whereas VASP localizes to F-actin–rich cores 
of protrusions, Mena is targeted to rings overlapping the 
F-actin– and Tks5-rich cores (Fig.  4  A and Videos 4 and 5). 
Despite differential localization of Mena and VASP, F-actin– 
and Tks5-rich cores of protrusions are readily detected by live 
cell imaging, but the ring-like pattern of Mena localization is 
often lost during the process of fixation and immunofluores-
cence staining, indicating that it may be transient in nature. As 
a result, only a minority of fixed invadopodia structures retain 
the Mena localization to rings at the distal end of F-actin– and 
cortactin-positive cores (Fig. S5, A and B).
To establish whether SHIP2 is required for localization of 
Mena or VASP to invadopodia, we examined their localization 
after the knockdown of SHIP2. Under SHIP2-depleted con-
ditions, actin- and cortactin-rich invadopodia-like protrusions 
form but fail to efficiently degrade matrix (Fig. S1, D and E). 
Although SHIP2 depletion had no effect on the stability of Mena 
or VASP (Fig. S5 D), it significantly reduced the localization of 
Mena at rings overlapping the F-actin core of invadopodia-like 
protrusions (9% of all invadopodia in SHIP2-depleted cells com-
pared with 72% in control cells; Fig. 4, A–C; and Videos 6 and 
7). A separate pool of Mena was still observed at focal adhesions, 
indicating that Mena localization to other sites in the cell is not 
abrogated (Videos 8 and 9 and Fig. 4 D). In contrast, SHIP2 
depletion had no effect on VASP localization to F-actin cores of 
invadopodia-like protrusions (Fig. 4, A and B), supporting the 
hypothesis that proteins other than SHIP2 recruit VASP to these 
F-actin–rich protrusions. Hence, the distinct pattern of Mena 
localization at invadopodia compared with VASP may reflect 
a differential dependence on SHIP2 for recruitment of Mena.
The ability of Mena and SHIP2 to colocalize at the ven-
tral cell surfaces, where invadopodia and focal adhesions form, 
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was also evaluated by time-lapse total internal reflection fluo-
rescent microscopy analysis. Mena was initially observed pre-
dominantly at the focal adhesions, whereas SHIP2 was mainly 
targeted to distinct punctate structures (Fig. S5 C). Analysis of 
time-lapse images revealed that over time, Mena accumulates 
within punctate SHIP2-positive regions, consistent with SHIP2 
recruiting Mena to these ventral cell protrusions (Fig. S5 C).
To establish whether SHIP2 is sufficient to recruit Mena to 
specific subcellular locations, we targeted SHIP2 to mitochon-
dria and examined its ability to redirect recruitment of Mena. In 
these experiments, we used WT-SHIP2 and SHIP2ΔFP4 fused 
with the mitochondria-targeting sequence (presequence) of Su9 
from ATPase subunit 9 of Neurospora crassa (Frederick et al., 
2008). Localization of both proteins at mitochondria was es-
tablished by costaining with a mitochondrial dye (MitoTracker 
red; Fig. S5 E). When coexpressed with mitochondria-targeted 
wild-type SHIP2 (Mito-SHIP2), Mena readily accumulated at 
the mitochondria, whereas it failed to localize to mitochon-
dria in cells expressing Mito-SHIP2ΔFP4 and instead pre-
dominantly localized to focal adhesions (Fig. 4 F). In contrast, 
VASP, when coexpressed with Mito-SHIP2, failed to localize 
to mitochondria (Fig. S5 F). These observations are consis-
tent with the biochemical evidence that the EVH1 domain of 
Mena is sufficient and necessary for interaction of Mena via 
the FP4 motif of SHIP2 (Fig. 4 E). Together, these data sup-
port that the FP4 motif of SHIP2 is required and sufficient for 
recruitment of Mena to specific SHIP2-enriched subcellular lo-
cations such as invadopodia.
SHIP2-mediated recruitment of Mena 
stabilizes invadopodia protrusions
To understand the functional consequences of SHIP2-dependent 
recruitment of Mena to invadopodia, we performed a series 
of short (1 frame/5 s for 5 min) time-lapse video microscopy 
analyses of the dynamics of invadopodia formation in SHIP2- 
depleted cells. Expression of either WT-SHIP2 or SHIP2ΔFP4 
Figure 3. SHIP2 interacts with the EVH1 domains of Mena and VASP via the FPP PP motif. (A) Schematic diagram depicts the SHIP2 consensus motif for the 
Mena and VASP EVH1 domains and corresponding sequences of the other known interaction partners of Mena and VASP (Zyxin, Lamellipodin, and Vin-
culin). (B) SHIP2 was immunoprecipitated from MDA-MB-231 cell lysates with either mouse (M) or rabbit (R) SHIP2 antibodies, or respective IgG controls, 
and immunoprecipitates were separated by SDS-PAGE and probed for Mena and VASP. (C) Coimmunoprecipitation was performed from MDA-MB-231 cell 
lysates with a mouse VASP antibody or mouse IgG control, and immunoprecipitates were probed for SHIP2, Mena, and VASP. (D) Coimmunoprecipitation 
was performed from MDA-MB-231 cell lysates expressing GFP-SHIP2 using a rabbit Mena antibody or rabbit IgG control, and immunoprecipitates were 
probed for SHIP2, Mena, and GFP. (E) HEK293 cells were transiently cotransfected with HA-SHIP2 or HA-SHIP2ΔFP4 and GFP-VASP as indicated, SHIP2 
was immunoprecipitated from the cell lysates with an anti-HA antibody, and immunoprecipitates were probed for the presence of GFP-VASP. (F) As in D, 
HA-SHIP2 or HA-SHIP2ΔFP4 and GFP-Mena were cotransfected as indicated and immunoprecipitated with an anti-HA antibody, and immunoprecipitates 
were probed for the presence of GFP-Mena. (G) HEK293 cells were transiently cotransfected with HA-SHIP2 and mutants of GFP-VASP (WT, VASPΔCC, 
VASPΔEVH1, and VASPΔCC and ΔEVH1) as indicated, SHIP2 was immunoprecipitated from the cell lysates with anti-HA antibody, and immunoprecipi-
tates were probed for the presence of GFP-VASP. (H) As in G, HA-SHIP2 and mutants of GFP-Mena (WT, MenaΔCC, MenaΔEVH1, and MenaΔCC and 
ΔEVH1) were cotransfected as indicated and immunoprecipitated with an anti-HA antibody, and immunoprecipitates were probed for the presence of 
GFP-Mena. (I) GST, GST-VASP-EVH1, and GST-Mena-EVH1 were coupled to glutathione-Sepharose beads and used to pull down interaction partners from 
the lysates of MDA-MB-231 cells. Resulting samples were probed for Vinculin and SHIP2 as indicated.
o
n
 O
ctober 6, 2016
D
ow
nloaded from
 
Published September 5, 2016
SHIP2 recruits mena to stabilize invadopodia • rajadurai et al. 725
Figure 4. SHIP2 recruits Mena, but not VASP, to promote proteolytically active invadopodia formation. (A) MDA-MB-231-pLKO.1 cells were transiently 
transfected with tagRFP-LifeAct and GFP-Mena or GFP-VASP and subjected to time-lapse video microscopy. Single frame illustrates the differential local-
ization of Mena and VASP with respect to filamentous actin at invadopodia protrusions. (B) As in A, MDA-MB-231-shSHIP2 cells were transiently trans-
fected with tagRFP-LifeAct and GFP-Mena or GFP-VASP and subjected to time-lapse video microscopy. Single frame illustrates that, under SHIP2-depleted 
conditions, Mena localizes to focal adhesions but not to filamentous actin at invadopodia protrusions, whereas VASP still localizes to filamentous actin 
at invadopodia protrusions. (C) GFP-Mena and tagRFP-LifeAct were transiently coexpressed in SHIP2-depleted MDA-MB-231 cells and subjected to the 
time-lapse imaging. Three different localization patterns of Mena relative to F-actin punctae (tagRFP-LifeAct) are observed. The relative distribution of Mena 
localization pattern under SHIP2-depleted condition compared with control is quantified and depicted as a pie chart. Quantification addresses percentage 
of invadopodia from 36 cells during the course of the video across three independent experiments. (D) MDA-MB-231-pLKO.1 and MDA-MB-231-shSHIP2 
cells were immunostained with Zyxin and Mena, and confocal images were acquired at the ventral surface. (E) GST and GST-Mena-EVH1 were coupled 
to glutathione-Sepharose beads and used to pull down interaction partners from the lysates of HEK293 cells transiently transfected with GFP-Vinculin, 
GFP-SHIP2, or GFP-SHIP2ΔFP4. Resulting samples were probed for GFP, Vinculin, and SHIP2 as indicated. (F) Mitochondria-targeted SHIP2 (Mito-SHIP2) 
or Mito-SHIP2ΔFP4 was transiently coexpressed together with mCherry-Mena in SKBr3 cells and immunostained as indicated to establish the localization 
of Mena with respect to SHIP2 and focal adhesions. All quantified data indicate the mean values ± SE from at least three independent experiments. 
Bars: 10 µm; (inset) 2 µm.
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supported formation of ventral F-actin–rich protrusions. How-
ever, in cells expressing the SHIP2ΔFP4 mutant, many of the 
newly formed F-actin–rich protrusions were transient in na-
ture, breaking into smaller protrusions and rapidly disappear-
ing (Video  10), whereas cells expressing WT-SHIP2 formed 
stable F-actin–rich protrusions (Video  10). Because Mena is 
an actin filament elongation factor, we assessed F-actin con-
tent. Overall F-actin content in MDA-MB-231-shSHIP2 cells 
rescued with SHIP2ΔFP4 was 33% lower compared with cells 
rescued with WT-SHIP2 (Fig.  5  D). Taking into account that 
Mena forms tetramers and functions as an actin filament elon-
gation factor that clusters filaments at barbed ends (Krause et 
al., 2003), we hypothesized that inefficient recruitment of Mena 
to invadopodia precursors diminishes elongation of actin fil-
aments required to support membrane protrusion. To address 
this possibility, cells expressing LifeAct, a fluorescent probe 
that binds to filamentous but not monomeric actin, were sub-
jected to FRAP analysis, using fluorescence recovery as a 
proportional readout for actin filament elongation. SHIP2ΔFP4- 
expressing cells exhibited a 60% decrease in the rate of recov-
ery after photobleaching (28% recovery after 50 s) compared 
with WT-SHIP2 cells (72% recovery after 50 s; Fig. 5, A and 
B). Hence, our data indicate that failure to recruit Mena leads 
to delayed elongation of actin filaments within nascent inva-
dopodia. Moreover, the actin-rich invadopodia-like protrusions 
that formed in SHIP2ΔFP4-expressing cells were smaller in di-
ameter (27%) than those that formed in WT-SHIP2–expressing 
cells (Fig. 5 C), consistent with defective assembly of the actin 
network within invadopodia precursors.
To determine whether delayed elongation of actin fila-
ments at nascent protrusions results in shorter invadopodia life-
time, we performed time-lapse imaging (1 frame/min for 1 h) 
of MDA-MB-231-shSHIP2 cells transiently expressing LifeAct 
and rescued with either WT-SHIP2 or SHIP2ΔFP4. Analysis of 
time-lapse imaging revealed that SHIP2ΔFP4 promotes inva-
dopodia that have shorter lifetimes compared with WT-SHIP2. 
Whereas 18% of F-actin protrusions that formed in MDA-MB-
231-shSHIP2 cells rescued with WT-SHIP2 displayed a life-
time of >1 h, all F-actin protrusions formed by cells rescued 
with SHIP2ΔFP4 displayed a lifetime of <1 h (Fig. 5 E), and 
the majority (63%) of invadopodia in SHIP2ΔFP4 cells had a 
lifetime of 0–10 min (Fig. 5, E and F). Collectively, these data 
demonstrate that SHIP2-mediated recruitment of Mena contrib-
utes to actin filament elongation at invadopodia sites and conse-
quently increases stability of these structures.
Mena, but not VASP, contributes to 
invadopodia-dependent ECM proteolysis 
and cell invasion
Given that the SHIP2ΔFP4 mutant is unable to rescue invado-
podia-mediated ECM degradation and that SHIP2 depletion 
abrogates localization of Mena, but not VASP, to nascent inva-
dopodia protrusions, we hypothesized that Mena but not VASP 
may play a critical role downstream from SHIP2 in invadopodia 
Figure 5. SHIP2 recruits Mena to regulate 
the actin network within the invadopodia 
membrane protrusions, hence invadopodia 
stability. (A) SHIP2-knockdown cells rescued 
with either WT-SHIP2 or SHIP2ΔFP4 were 
transiently transfected with tagRFP-LifeAct and 
subjected to FRAP analysis on F-actin–rich 
protrusions. Time series of WT-SHIP2 and 
SHIP2ΔFP4 rescued cells illustrate the delay 
in fluorescence recovery. (B) FRAP analysis 
was performed as described in A, and fluores-
cence recovery of 30 invadopodia protrusions 
acquired from three independent experiments 
from WT-SHIP2– and SHIP2ΔFP4-rescued cells 
was quantified 50 s after photobleaching. (C) 
SHIP2-knockdown cells rescued with either 
WT-SHIP2 or SHIP2ΔFP4 were transiently 
transfected with tagRFP-LifeAct and subjected 
to live time-lapse imaging, and the diameter 
of at least 200 invadopodia-like protrusions 
from three independent experiments were 
measured. (D) Filamentous actin content was 
measured from SHIP2-knockdown cells res-
cued with either WT-SHIP2 or SHIP2ΔFP4 and 
expressed as fold change. (E) SHIP2-knock-
down cells rescued with either WT-SHIP2 or 
SHIP2ΔFP4 were transiently transfected with 
tagRFP-LifeAct and subjected to time-lapse 
video microscopy. Invadopodia lifetime was 
analyzed for 120 invadopodia from cells 
rescued with WT-SHIP2 and 85 invadopodia 
from cells rescued with SHIP2ΔFP4 and ex-
pressed as binned data. (F) As in E, mean life-
time was calculated for invadopodia formed in 
cells rescued with WT-SHIP2 and SHIP2ΔFP4. 
Invadopodia with lifetimes of less than 1 hour 
were considered for this analysis. All quanti-
fied data indicate the mean values ± SE from 
at least three independent experiments. *, P < 
0.05; **, P < 0.01; NS, not statistically signif-
icant. Bars: 10 µm; (inset) 2 µm.
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maturation and ECM degradation. To test this possibility, using 
lentiviral transduction, we established stable cell populations of 
MDA-MB-231 cells expressing two different shRNA duplexes 
targeting Mena or VASP. Stable depletion of Mena led to a 
significant decrease in formation of proteolytically active inv-
adopodia (43% of control; Fig. 6, A and B), ECM degradation 
(44% of control; Fig. 6, A and C), and cell invasion (47% of 
control; Fig. 6, D and E), whereas depletion of VASP resulted 
in a modest decrease in cell invasion (retaining 75% of control; 
Fig. 6, D and E) but had no significant effect on invadopodia 
formation (Fig.  6, A–C). Collectively, these data support that 
Mena, but not VASP, functions downstream from SHIP2 in for-
mation of proteolytically competent invadopodia, resulting in 
increased invasion of the extracellular matrix.
Ring-like localization of Mena contributes 
to proteolytic activity
All Ena/VASP proteins have similar domain organization and 
share several interaction partners; however, Mena has features 
that are not found in VASP and hence may be required for 
invadopodia-related functions. Among these are LER ER re-
peats located between the EVH1 domain and the proline-rich 
sequence of Mena (Fig.  7  A). To determine which domains 
within Mena contribute to its targeting to invadopodia and in-
vadopodia maturation into ECM-degrading structures, we gen-
erated Mena mutant proteins lacking either the EVH1 domain 
(MenaΔEVH1) or LER ER repeats (MenaΔLER ER) and exam-
ined their localization at the ventral F-actin–rich punctae. When 
expressed in Mena-depleted MDA-MB-231 cells, WT-Mena is 
enriched in a ring surrounding the distal ends of F-actin cores. 
In contrast, MenaΔEVH1 failed to localize to the F-actin punc-
tae (Fig. 7 B), and MenaΔLER ER failed to target to ring-like 
structures and was found predominantly at the F-actin core in 
a pattern reminiscent of VASP localization (Fig. 7 B). Collec-
tively, these data support that the EVH1 domain is required for 
recruitment of Mena to F-actin–positive membrane protrusions, 
whereas LER ER repeats are required for retention of Mena at 
the distal ends of the F-actin cores.
To determine the functional consequences of differential 
localization of Mena within invadopodia (ring-like vs. punc-
tate), we rescued MDA-MB-231-shMena cells with WT-Mena, 
MenaΔEVH1, or MenaΔLER ER and assayed transfected 
cells for their ability to form proteolytically active invadopo-
dia and degrade ECM. Stable depletion of Mena in invasive 
MDA-MB-231 breast cancer cells resulted in no significant 
difference in the number of F-actin– and cortactin-positive 
Figure 6. Mena, but not VASP, promotes proteolytically active invadopodia formation and cell invasion. (A–C) MDA-MB-231 cells were stably transduced 
with pLKO.1 or two individual shRNA duplexes targeting Mena or VASP. (A) Cells were seeded on fluorescently labeled gelatin and stained with phalloidin 
(F-actin), and confocal images were acquired. (B) The percentage of VASP- or Mena-knockdown cells that formed proteolytically active invadopodia was 
quantified in comparison to control cells. (C) Amounts of ECM degradation by VASP- or Mena-knockdown cells were quantified as fold change compared 
with control cells. (D) MDA-MB-231 cells stably transduced with pLKO.1 or individual shRNA duplexes targeting VASP or Mena were subjected to an 
inverted invasion assay. Representative confocal z-stacks depict relative cell invasion. (E) For quantification of cell invasion, five confocal z-stacks per condi-
tion per experiment were acquired. Fluorescence intensity of the planes within each z-stack was measured using Cell Profiler software. Cells invading to and 
past 30 µm inside the matrix were quantified as percentage of total cell population. Experiments were repeated four times. Western blot reveals the relative 
protein levels of VASP and Mena between different MDA-MB-231 cells stably transduced with pLKO.1 and individual shRNA duplexes targeting VASP or 
Mena. All quantified data indicate the mean values ± SE from at least three independent experiments. *, P < 0.05; **, P < 0.01. Bars: 10 µm; (inset) 2 µm.
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punctae (Fig. 7 C), although the punctae per se appear smaller 
(not depicted). However, loss of Mena led to a 52% reduction 
in the number of cells with proteolytically active invadopodia 
(Fig.  7  D) and a 42% decrease in overall matrix degradation 
capacity (Fig.  7  E). In support of this result, reexpression of 
WT-Mena rescued both invadopodia formation (≈129% of con-
trol) and ECM degradation (≈126% of control) to levels simi-
lar to or greater than those observed in control cells expressing 
endogenous Mena (Fig. 7, D and E). Reexpression of neither 
MenaΔEVH1 nor MenaΔLER ER fully rescued invadopodia 
formation (47% and 46% of control, respectively) and ECM 
degradation (60% and 61% of control, respectively; Fig. 7, D 
and E). MenaΔLER ER failed to rescue invadopodia-mediated 
matrix degradation despite recruitment to the F-actin cores of 
nascent invadopodia, implying a role for the LER ER repeats 
in MMP secretion. Collectively, these data support that the 
LER ER repeats retain Mena at the distal ends of the F-actin–
rich cores of invadopodia and promote recruitment of MT1-
MMP to invadopodia sites.
SHIP2 phosphatase activity and proline-
rich sequence are required for cell 
invasion in vivo
To assess the in vivo relevance of SHIP2–Mena interaction for 
cancer cell invasion and metastasis, we used the bone-specific 
metastatic variant of MDA-MB-231 cells (1833-TR) stably 
tagged with a luciferase reporter (Kang et al., 2003) that al-
lows visualization of tumor growth. Stable populations of 
1833-TR cells expressing SHIP2 shRNA or vector were estab-
lished, and SHIP2-depleted cells were rescued to similar levels 
of expression with WT-SHIP2, the catalytic inactive SHIP2 
mutant (SHIP2-D608A), or SHIP2 uncoupled from Mena 
(SHIP2ΔFP4; Fig.  8  C). All of the resulting cell lines were 
able to colonize the lungs when injected in the tail vain of nude 
mice, with detectable tumor growth starting 5 wk after injection 
(Fig. 8, A and B). In all cases, ∼90% of mice developed lung 
tumors with similar growth rates (Fig. 8, B and E). Microscopic 
examination of lung lesions by hematoxylin and eosin staining 
revealed that although total tumor volume was similar across 
all conditions, numbers and gross morphology of the lesions 
were distinct (Fig.  8, D and G). Specifically, mice injected 
with SHIP2-depleted cells and rescued with SHIP2-D608A or 
SHIP2ΔFP4 developed fewer lung lesions (46%) and a prefer-
ence for growth in peripheral capillaries compared with mice 
injected with cells rescued with WT-SHIP2 (Fig. 8, D and G).
Although incidence and growth rate of tumors in lungs were 
similar across all conditions, differences were observed in the 
ability of the rescued cell lines to escape the lungs and colonize 
other organs, predominantly the bones (Fig. 8, A and F). Whereas 
∼40% of mice injected with 1883-TR-pLKO.1 cells developed 
bone lesions, mice injected with SHIP2-depleted cells had no de-
tectable lesions (Fig. 8 F). Reexpression of WT-SHIP2 resulted 
in an increase of bone lesion incidence to ∼60%, whereas expres-
sion of SHIP2-D608A or SHIP2ΔFP4 resulted in only ∼10% of 
injected mice developing bone lesions (Fig. 8 F), consistent with 
decreased potential of these SHIP2 mutants to support invado-
podia formation and ECM degradation. Hence, collectively, our 
data demonstrate a requirement for SHIP2 for cell invasion and 
metastasis in vivo that requires both intact phosphatase activity 
and its function as a molecular scaffold to recruit Mena.
Figure 7. Mena is recruited to invadopodia via its 
EVH1 domain and requires the LER ER sequences for 
its ring-like localization and proteolytic activity. (A) 
Schematic diagram of Mena depicts its EVH1 domain, 
LER ER repeats, proline-rich region, and the EVH2 do-
main. (B) MDA-MB-231-shMena cells were transiently 
transfected with tagRFP-LifeAct and GFP-MenaΔEVH1 
or GFP-MenaΔLER ER and subjected to time-lapse 
video microscopy. Single frame illustrates GFP-
MenaΔEVH1 and GFP-MenaΔLER ER localization with 
respect to F-actin cores of invadopodia protrusions. 
(C) MDA-MB-231-pLKO.1, MDA-MB-231-shMena, 
and MDA-MB-231-shMena cells transiently rescued 
with WT-Mena, MenaΔEVH1, or MenaΔLER ER were 
seeded on unconjugated gelatin matrix and immunos-
tained for invadopodia markers (F-actin and cortactin), 
and confocal images were acquired at the ventral cell 
surface. The number of F-actin– and cortactin-positive 
protrusions per cell was quantified. (D) MDA-MB-231-
pLKO.1, MDA-MB-231-shMena, and MDA-MB-231-
shMena cells transiently rescued with WT-Mena, 
MenaΔEVH1, or MenaΔLER ER were seeded on flu-
orescent gelatin matrix and immunostained with phal-
loidin (F-actin), confocal images were acquired at the 
ventral cell surface, and the percentage of cells that 
formed proteolytically active invadopodia (positive 
for F-actin punctate overlaying matrix degradation 
area) was quantified. (E) As in D, invadopodia assay 
was performed, and the amount of ECM degradation 
(mean matrix degradation area per fields of view) by 
MDA-MB-231-pLKO.1, MDA-MB-231-shMena, and 
MDA-MB-231-shMena cells transiently rescued with 
WT-Mena, MenaΔEVH1, or MenaΔLER ER was quan-
tified as fold change compared with control (pLKO.1) 
cells. All quantified data indicate the mean values ± 
SE from at least three independent experiments. **, P 
< 0.01. Bars: 10 µm; (inset) 2 µm. o
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Discussion
Elevated expression of the 5′-inositol phosphatase SHIP2 is ob-
served in aggressive cancers and is associated with increased 
invasive capacity (Prasad et al., 2008; Fu et al., 2013, 2014; 
Yang et al., 2014), yet its role in cell invasion is still poorly 
understood. Here we identify a critical regulatory function for 
SHIP2 in maturation of invadopodia into proteolytically active 
structures that enhance invasive capacity in 3D cultures in vitro 
and in vivo. This was achieved by analyzing invadopodia for-
mation and maturation and cancer cell invasion under condi-
tions in which SHIP2 levels were depleted and rescued with 
SHIP2 mutants. These multiple approaches yielded quantita-
tive, complementary results that support a model wherein can-
cer cell invasion requires both the lipid phosphatase activity of 
SHIP2 and an unexpected role for SHIP2 as a scaffold protein 
that recruits the actin regulatory protein Mena to invadopodia. 
The localization of a SHIP2/Mena complex to invadopodia is 
dependent on the SHIP2 SH2 domain and its ability to couple 
with tyrosine-phosphorylated cortactin, a key protein in inva-
dopodia formation. SHIP2-dependent recruitment of Mena to 
cortactin within nascent invadopodia is required for invado-
podia maturation and recruitment of matrix metalloproteases, 
which is required for matrix degradation and cell invasion.
SHIP2 uses the PI3K product phosphoinositide, Ptd-
Ins(3,4,5)P3, as a high-affinity substrate to yield PtdIns(3,4)P2. 
Nascent invadopodia (early membrane protrusion) are predomi-
nantly enriched in PtdIns(3,4,5)P3, which suffices to recruit the 
regulators of the Arp2/3 actin nucleation complex, cortactin and 
N-WASP, and hence trigger the nucleation of actin filaments at 
sites of invadopodia initiation. A local switch in phosphoinositide 
composition from PtdIns(3,4,5)P3 to PtdIns(3,4)P2 at nascent 
invadopodia provides docking sites for the Tks4/Tks5 family of 
scaffolding proteins (Sharma et al., 2013). Recruitment of Tks5 
Figure 8. SHIP2 phosphatase activity and capacity to interact with Mena are required for cell invasion in vivo. (A) Mice injected (tail vein) with a MDA-
MB-231-1833-TR bone metastatic variant expressing vector (pLKO.1), SHIP2 shRNA, or SHIP2 shRNA plus GFP-SHIP2-WT, GFP-SHIP2-D608A, or GFP-
SHIP2ΔFP4 were imaged to detect luciferase activity. Bioluminescence images of two representative mice per condition acquired immediately and 1 and 7 
wk after injection are depicted. (B) Tumor growth within lungs, for mice injected with cells as indicated in A, was quantified and expressed as fold change of 
initial inoculum on day 0. (C) SDS-PAGE followed by Western blot analysis depicts protein levels of SHIP2 between MDA-MB-231-1833-TR cells transduced 
with pLKO.1 and shSHIP2 as well as exogenous rescue levels of GFP-SHIP2-WT, GFP-SHIP2-D608A, and GFP-SHIP2ΔFP4. (D) Number of lung lesions per 
mouse was quantified based on hematoxylin and eosin staining of serial step sections of paraffin embedded tissue. (E) Table summarizes the cells injected 
via tail vein and their respective take rate for tumor growth at the lungs. (F) Table summarizes the cells injected via tail vein and their respective tumor spread 
and growth rate outside lungs. (G) Representative hematoxylin and eosin staining of a single section of all five lobes of mouse lung shows characteristic 
lesions among different conditions. All quantified data indicate the mean values ± SE. *, P < 0.05; NS, not statistically significant. Bars, 4 mm.
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to PtdIns(3,4)P2-enriched invadopodia membranes via its PX do-
main anchors the Arp2/3 complex via interactions with Nck and 
N-WASP and, as a result, promotes nucleation of actin filaments 
that sustain membrane protrusion and subsequent delivery of 
metalloprotease MT1-MMP to invadopodia (Stylli et al., 2009).
This process is consistent with our observations that 
SHIP2 is indispensable for invadopodia stability and maturation 
and SHIP2 catalytic activity contributes to the recruitment and 
anchoring of Tks5. In SHIP2-depleted cells rescued with a lipid 
phosphatase inactive mutant of SHIP2 (SHIP2-D608A), a sig-
nificant percentage of nascent cortactin- and F-actin–positive 
invadopodia are negative for Tks5 (43% compared with only 
9% rescued with WT-SHIP2; Fig.  2). Cortactin accumulation 
precedes Tks5 recruitment to nascent invadopodia, and tyrosine 
phosphorylation of cortactin is required for invadopodia mat-
uration (Magalhaes et al., 2011; Beaty et al., 2013; Sharma et 
al., 2013). We identified a specific interaction between SHIP2 
and cortactin that is dependent on tyrosine phosphorylation of 
cortactin and an intact SH2 domain of SHIP2, implying a role 
for cortactin in recruiting SHIP2 to nascent invadopodia. In 
support of this, a SHIP2 mutant lacking a functional SH2 do-
main (SHIP2ΔFP4-R47G) is not recruited to nascent F-actin– 
positive invadopodia protrusions (Figs. 2 and S3; Video  2), 
consistent with decreased conversion of PtdIns(3,4,5)P3 into 
PtdIns(3,4)P2 and decreased recruitment of Tks5 (Fig. 2).
Structure–function analyses revealed that SHIP2 contains 
a consensus binding sequence for the EVH1 domain of the Ena/
VASP family of actin elongation factors (Bear and Gertler, 
2009). The actin filament elongation factors, Ena/VASP family 
proteins Mena and VASP, are known to localize at invadopo-
dia, yet modes of their recruitment to invadopodia had not been 
elucidated (Philippar et al., 2008; Schoumacher et al., 2010). 
A SHIP2 mutant lacking the Ena/VASP consensus binding se-
quence (SHIP2ΔFP4) fails to induce invadopodia capable of 
ECM degradation (Fig. 1). Moreover, we demonstrate a direct 
interaction between SHIP2 and Mena/VASP and provide evi-
dence that SHIP2 localizes Mena but not VASP to invadopodia 
(Figs. 3 and 4). Depletion of SHIP2 decreases Mena, but not 
VASP, localization within invadopodia, and a mitochondria- 
targeted SHIP2 recruits Mena, but not VASP, to mitochondria 
(Fig. 4). These results support a specific role for Mena down-
stream from SHIP2 in invadopodia biogenesis. Invadopodia pro-
trusions formed in cells expressing SHIP2ΔFP4 were smaller in 
diameter than those of cells expressing WT-SHIP2, perhaps be-
cause of impaired capacity to elongate actin filaments that sus-
tain membrane protrusion (Fig. 5). Because the ability of both 
Mena and VASP to bind SHIP2 relies on their EVH1 domains, 
differential affinity of the Mena and VASP EVH1 domains for 
the FP4 consensus sequence within SHIP2 may be a likely ex-
planation that calls for further investigation. In support of this, 
the tumor suppressor protein, Tes, shows selective interaction 
with Mena over the VASP EVH1 domain through the Tes LIM 
domain (Boëda et al., 2007; Small, 2008).
Localization of Mena and VASP at invadopodia and their 
main function as actin elongation factors pose the question of 
their functional redundancy during invadopodia biogenesis. In 
our experiments, depletion of Mena, but not VASP, abrogated 
invadopodia-mediated matrix remodeling (Fig. 6). Nonetheless, 
depletion of VASP was associated with a less pronounced re-
duction in cell-invasive potential than depletion of Mena. This 
observation may reflect involvement of VASP in alternative pro-
tease-independent mechanisms of invasion.
Increased expression of Mena is found in high-risk pre-
neoplastic lesions and correlates with augmented tumor inva-
siveness and poor prognosis in breast cancer patients (Gertler 
and Condeelis, 2011; Oudin et al., 2016a). Precise mechanistic 
functions of Mena in targeted delivery of vesicular MMPs to na-
scent invadopodia sites remain unclear. One model argues that 
Mena recruitment increases elongation of actin filaments within 
invadopodia structures, leading to membrane protrusion that in 
turn serves as a signal to trigger targeted delivery of MMPs. 
Another possibility is that the ability of Mena to couple tar-
geted delivery of MMPs to nascent invadopodia protrusions is 
determined by the presence of additional sequence features that 
are not found in VASP, such as the LER ER repeats between 
the EVH1 domain and the PRS. In support of this, the integrin 
αVβ3 complex, like VASP, localizes to invadopodia as punctae, 
whereas the α5β1 complex localizes as a ring overlapping the 
punctae (Mueller et al., 1999; Branch et al., 2012). Intriguingly, 
the ring-like distribution of Mena within invadopodia is remi-
niscent of the adhesion rings described by Branch et al. (2012). 
Formation of these adhesion rings is highly dependent on in-
tegrin activity and correlates with targeted delivery of MT1-
MMP and capacity to proteolytically remodel ECM (Branch et 
al., 2012). Mena can bind the cytoplasmic tails of α5 integrin 
via LER ER repeats and activate inside-out α5β1 integrin sig-
naling (Gupton and Gertler, 2010; Oudin et al., 2016b). Mena- 
mediated activation of the α5β1 integrin complex promotes exo-
cytosis initiated by the exocyst complex containing Exo70 and 
VAMP7, both of which can regulate MMP secretion at invado-
podia (Sakurai-Yageta et al., 2008; Steffen et al., 2008; Gupton 
and Gertler, 2010; Monteiro et al., 2013). In view of these find-
ings, the ring pattern of Mena localization within invadopodia 
may reflect its potential requirement for inside-out activation 
of α5β1 integrin complexes, coupling vesicular trafficking of 
MMPs to invadopodia protrusions.
Mena mRNA has been reported to undergo alternative 
splicing events, resulting in expression of multiple tissue- 
specific protein isoforms that can elicit differential biological 
responses (Gertler and Condeelis, 2011). The most character-
ized Mena isoforms are MenaINV and MenaΔv6. MDA-MB-231 
invasive breast cancer cells express a specific Mena isoform that 
lacks exon 6 (MenaΔv6). Expression of this isoform is asso-
ciated with increased cell motility (Di Modugno et al., 2012). 
Therefore, it is possible that, in MDA-MB-231 cells, MenaΔv6 
cooperates with SHIP2 to promote invadopodia-mediated ma-
trix remodeling and cell invasion. In addition, circulating tumor 
cells, micrometastatic lesions, and the invasive front of bulk 
primary tumor also express another isoform of Mena, MenaINV, 
which includes a 19-aa exon (Goswami et al., 2009; Gertler and 
Condeelis, 2011; Oudin et al., 2016a). Expression of MenaINV 
has only been observed in vivo, implying its regulation by the 
tumor microenvironment (Gertler and Condeelis, 2011). Deple-
tion of SHIP2 had no effect on the ability of MDA-MB-231 
cells to colonize lungs in nude mice upon tail vein injection 
but decreased the ability of tumor cells to subsequently escape 
the lungs, enter the bloodstream, and colonize distant organs 
(mainly bone). These findings support a role for SHIP2 in cell 
invasion in vivo (Fig. 8). Moreover, whereas expression of WT-
SHIP2 in SHIP2-depleted MDA-MB-231 cells rescued this 
metastatic phenotype, expression of SHIP2 uncoupled from 
Mena failed to rescue metastasis to the bones (Fig.  8). This 
may be caused by the inability of SHIP2ΔFP4 to cooperate 
with Mena or MenaINV and trigger invadopodia-mediated ECM 
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remodeling. In agreement with this rationale, overexpression of 
MenaINV prolongs invadopodia lifetime in vitro and promotes 
distant metastasis in vivo (Philippar et al., 2008).
Collectively, our findings reveal a dual role of SHIP2 in 
coupling nascent actin-rich membrane protrusions to targeted 
MMP secretion, thus leading to maturation of invadopodia into 
structures competent for ECM degradation. First, SHIP2 pro-
motes PtdIns(3,4)P2-mediated recruitment of Tks5 that anchors 
the Arp2/3 actin nucleation complex. Second, it directly recruits 
Mena to concomitantly elongate newly nucleated actin fila-
ments, thereby regulating the architecture of the actin network 
that sustains membrane protrusion. Therefore, pharmacological 
disruption of SHIP2–Mena interaction may hold a therapeutic 
potential for metastatic disease. In summary, our work provides 
novel insights into the molecular mechanisms governing inva-
dopodia biogenesis and identifies new avenues for specific ther-
apeutic targeting of SHIP2 invadopodia-related functions.
Materials and methods
Cell culture and transfection
HEK293, SKBr3, and MDA-MB-231 cells were maintained in DMEM 
containing 10% FBS. Transient transfections of HEK293 cells were 
performed using Lipofectamine/Plus reagent, and transfections of 
MDA-MB-231 and SKBr3 cells were performed using Lipofectamine 
2000, according to the manufacturer’s instructions (Invitrogen). The 
following shRNA sequences (Thermo Fisher Scientific) were used to 
establish stable SHIP2 depletion: shSHIP2-A (5′-CCG GGC AGC TCA 
 ATG CCT TTG ACA TCT CGA GTG TCA AAG GCA TTG AGC TGC TTT 
TTG-3′), shSHIP2-B (5′-CCG GCC TGA ACT ACA TCA GCA GGA ACT 
CGA GTT CCT GCT GAT GTA GTT CAG GTT TTTG-3′), and shSHIP2-C 
(5′-CCG GCC GGA TTC TGT GGA AAT CCT ACT CGA GTA GGA TTT CC 
A CAG AAT CCG GTT TTTG-3′). Cells stably expressing shSHIP2-C 
were used to establish stable rescue lines.
Antibodies and reagents
Commercial antibodies to SHIP2, Mena, and VASP (rabbit) were ob-
tained from Cell Signaling Technology; SHIP2 and VASP (mouse) from 
Santa Cruz Biotechnology, Inc.; vinculin, actin, and tubulin from Sigma- 
Aldrich; GFP antibody, phalloidin Alexa Fluor 546, and Alexa Fluor 
488– and 555–conjugated secondary antibodies from Thermo Fisher Sci-
entific; and HA.11 monoclonal antibody from Covance. HA-SHIP2 and 
GFP-SHIP2 were gifts from C.A. Mitchell (Monash University, Clayton, 
Australia) and K. Kaibuchi (Nagoya University, Nagoya, Japan), respec-
tively. GFP-VASP and GFP-Mena were gifts from F. Gertler (Massachu-
setts Institute of Technology, Cambridge, MA). pLifeAct-TagRFP was 
purchased from Ibidi. Point mutants of pEGFP-N3-SHIP2 were gener-
ated by site-directed mutagenesis using a kit from Stratagene (Agilent 
Technologies). Deletion mutants of pEGFP-N3-SHIP2, GFP-VASP, and 
GFP-Mena were generated by PCR amplification. mCherry-Mena and 
pLXSN-SHIP2 WT and mutants were generated by subcloning. Mito-
chondria targeting vector (MITO-GFP) was generated by subcloning the 
presequence of Su9 from ATPase subunit 9 of N. crassa into pGFP-C2 
vector (Frederick et al., 2008). MITO-SHIP2 was generated by PCR 
amplification of SHIP2 and insertion into the EcoRI and XhoI sites 
of the MITO-GFP vector. SHIP2 deletion mutants lacking aa 18–108 
(SHIP2ΔSH2) and 1,048–1,059 (SHIP2ΔFP4) were generated by PCR.
Immunoprecipitation and Western blotting
Cells were harvested in lysis buffer (150  mM NaCl, 20 nM Tris-
HCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, and 1% sodium 
deoxycholate, pH 7.4) supplemented with 1 mM PMSF, 1 mM sodium 
vanadate, 1  mM sodium fluoride, 10 µg/ml aprotinin, and 10 µg/ml 
leupeptin. For immunoprecipitation, lysates were incubated with the 
indicated antibodies for 2  h at 4°C with gentle rotation followed by 
the addition of 30 µl of a 50% slurry of either protein A–Sepharose or 
protein G–Sepharose (GE Healthcare) and an additional hour of gentle 
rotation before the collection of immune complexes. The resulting im-
mune complexes were washed three times with lysis buffer, eluted with 
SDS sample buffer, and resolved by SDS-PAGE. Bound proteins were 
visualized using an ECL detection kit (GE Healthcare) as described 
previously (Rajadurai et al., 2012).
GST pull-down assay
Cell lysates were precleared with glutathione-Sepharose beads for 1 h 
at 4°C, and 5 µg fusion protein was immobilized on 25 µl glutathione- 
Sepharose beads at RT. MDA-MB-231 cell lysates were incubated 
with glutathione-Sepharose beads loaded with GST alone, GST-VASP-
EVH1, or GST-Mena-EVH1 for 2 h at 4°C. The resulting samples were 
washed three times with lysis buffer, eluted with SDS sample buffer, 
resolved by SDS-PAGE, and subjected to Western blotting.
Inverted invasion assay
Inverted invasion assays were performed as described previously 
(Caswell et al., 2007). In brief, modified Boyden chambers with 8-µm 
membrane pore size were coated with a mixture of Matrigel (BD) and 
acid-purified rat-tail collagen (Gibco) at final concentrations of 2.5 mg/
ml of each for 2 h at 37°C.  Inserts were then inverted, and 106 cells 
were seeded directly onto the opposite surface of the filter and allowed 
to adhere for 4 h at 37°C and 5% CO2. After 4 h, filters were inverted, 
and the top compartments of the chambers were filled with DMEM 
plus 10% FBS, and the bottom compartments with plain DMEM. Cells 
were allowed to invade through the matrix for 72 h and were stained 
with Calcein-AM (Invitrogen) according to the manufacturer’s instruc-
tions; cells that did not enter the matrix were removed using cotton 
swabs. Invading cells were visualized by confocal microscopy, and se-
rial confocal sections (z-stacks) were acquired at 10-µm intervals. The 
fluorescence intensity reflecting the number of invading cells was then 
measured for each section using Cell Profiler software (Stöter et al., 
2013), and cells invading into the matrix at least 30 µm and beyond were 
quantified as the percentage of total cell population within the matrix.
Fluorescent gelatin degradation assay
Glass coverslips were coated with poly-d-lysine for 20 min, washed 
three times with PBS, incubated for 20 min in 0.5% glutaraldehyde 
(Sigma-Aldrich), and washed three times with PBS. Fluorescein- 
conjugated gelatin (Invitrogen) was diluted to 20 µg/ml in 0.1% un-
conjugated gelatin (STE MCE LL Technologies), and the resulting 
mixture was incubated on coverslips at 37°C for 1 h. Coverslips were 
then washed three times with PBS and quenched in 5 mg/ml sodium 
borohydride. Coverslips were washed again three times with PBS and 
sterilized in 70% ethanol for 20 min. Finally, coverslips were washed 
with DMEM, and 5 × 104 cells were seeded and incubated at 37°C and 
5% CO2 for 24 h, unless specified otherwise. Cells were fixed with 4% 
PFA and stained according to accepted immunofluorescence protocol.
Live cell imaging
Live cell imaging was performed as described previously (Rajadurai et 
al., 2012) using an Axiovert 200 microscope (ZEI SS) and Apochromat 
1.4-NA 100× objective. In brief, cells grown on the 35-mm glass-bottom 
dishes (Ibidi) coated with either fluorescently labeled or nonconju-
gated gelatin were positioned on the motorized stage on the inverted 
microscope Axiovert 200M (ZEI SS), equipped with a 100× planApo 
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1.4-NA objective, AxioCam HRM (ZEI SS) digital camera, and a small 
transparent environmental chamber Climabox (ZEI SS) with 5% CO2 at 
37°C. The microscope was controlled by the AxioVision LE software 
(ZEI SS). Images were collected at set time intervals and analyzed using 
the MetaMorph software.
FRAP
Images were acquired using a 63×, 1.7-NA oil-immersion objective on 
a 710 laser scanning confocal microscope (ZEI SS). Cells were kept in a 
heated (37°C) CO2 (5%) chamber throughout the experiment. The 561-
nm laser line was used to excite RFP. Photobleaching was achieved by 
100% laser illumination of a region of interest. Low-intensity illumina-
tion (2%) was used to record fluorescence before and after bleaching for 
a total time period of 5 min. Mean pixel intensity was evaluated using 
ZEN2009/2011 software. Data were corrected for background fluctua-
tions and bleaching artifacts and normalized to prebleaching intensity. 
The recovered fluorescence intensity was calculated as follows: (IP − 
I0)/(II − I0), where II is the initial intensity measured before bleaching, 
I0 is the immediate fluorescence intensity after bleaching, and IP is the 
postbleaching values of the recovery intensities. Fluorescence recovery 
was calculated 60 s after photobleaching for graphical representation.
F-actin measurement
F-Actin was quantified as previously described (Diakonova et al., 
2002). In brief, 7 × 105 cells per well were plated in six-well dishes. 
After 5 h, cells were fixed in 4% PFA for 20 min, permeabilized with 
0.1% Triton-100 for 20 min, and stained with 250 nM rhodamine phal-
loidin in PHEM buffer for 30 min in the dark. After three washes with 
PBS, cells were scraped off with 700 µl methanol and extracted for 24 h 
at −20°C.  Extracted rhodamine-phalloidin was measured at 540 nm 
using a spectrofluorometer.
Tail vein injection and metastatic tumor growth in vivo
Female nude mice (6–8 wk old) were injected into the tail vein with 
105 MDA-MB-231-1833-TR cells expressing pLKO.1 vector, shRNA 
against SHIP2, and, in addition to SHIP2 shRNA, exogenous GFP-
SHIP2-WT, GFP-SHIP2-D608A, or GFP-SHIP2ΔFP4. Luciferase ac-
tivity in the lungs was confirmed immediately after injection using an 
IVIS 100 (Caliper Life Sciences) bioluminescence imaging system as 
previously described (Knight et al., 2013). Mice were imaged once a 
week thereafter, and luciferase activity was monitored to detect tumor 
growth in the lungs and distant metastasis to other organs. Luminescence 
signal within the lungs was measured and quantified as fold change of 
initial inoculum as described in Mourskaia et al. (2012). Mice were sac-
rificed 8 wk after injection, and distant metastasis to other organs, includ-
ing bones and lymph nodes, was evaluated. Tissues with tumorigenic/
metastatic lesions (lungs, mandibles, vertebrae, sternum, and tibia/fib-
ula) were collected at necropsy for histological analysis. Tissue samples 
were fixed in either 10% formalin (lungs and lymph nodes) or 4% PFA 
(bones), embedded in paraffin, and sectioned (50-µm step sections). Tis-
sue sections were stained with hematoxylin and eosin and imaged using 
an Aperio-XT slide scanner (Aperio). The number of lesions throughout 
the lung (step sections) was quantified. All animal experiments were 
performed in accordance with the guidelines of the McGill University 
animal ethics committee and the Canadian Council on Animal Care as 
approved by the facility animal care committee (protocol #5562).
Statistical analyses
All statistical analyses were performed using Microsoft Excel. Graphed 
data represent the mean values ± standard error (SE) from at least three 
independent experiments. Two-tailed, paired Student’s t test was used 
to determine the statistical significance unless otherwise specified.
Online supplemental material
Fig. S1 shows the ability of SHIP2-depleted MDA-MB-231 cells 
to form functional invadopodia and invade the ECM. Fig. S2 shows 
the migratory capacity of SHIP2-depleted MDA-MB-231 cells. Fig. 
S3 shows the localization of various SHIP2 mutants to invadopodia. 
Fig. S4 shows that intersectin is dispensable for functional 
invadopodia formation. Fig. S5 shows that whereas VASP localizes 
to the invadopodia core, Mena localizes as a ring at the distal tip of 
invadopodia core. It also shows that the differential localization of 
Mena and VASP is caused by the ability of SHIP2 to recruit Mena, but 
not VASP, to invadopodia. Video 1 shows that SHIP2 depletion does 
not affect random cell migration in MDA-MB-231 cells. Video 2 shows 
that SHIP2ΔFP4-R47G fails to localize to actin-rich invadopodia 
protrusions. Video  3 shows matrix degradation under F-actin–rich 
membrane protrusions in MDA-MB-231 cells. Video  4 shows the 
localization of Mena in a ring around the actin core within invadopodia. 
Video  5 shows the localization of Mena in a ring around the Tks5 
core within invadopodia. Video  6 shows that depletion of SHIP2 
affects Mena localization with respect to F-actin core of invadopodia. 
Video 7 shows that depletion of SHIP2 affects Mena localization with 
respect to Tks5 core of invadopodia. Video 8 shows that depletion of 
SHIP2 does not affect Mena localization to Paxillin-positive focal 
adhesions. Video 9 shows that depletion of SHIP2 does not affect Mena 
localization to Zyxin-positive focal adhesions. Video 10 shows that a 
SHIP2 mutant uncoupled from Mena destabilizes actin-rich membrane 
protrusions at the ventral surface of MDA-MB-231 cells. Online 
supplemental material is available at http ://www .jcb .org /cgi /content /
full /jcb .201501003 /DC1.
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